- Home
- MCD vs AZN Comparison
MCD vs AZN Comparison
Compare MCD & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCD
- AZN
- Stock Information
- Founded
- MCD 1940
- AZN 1992
- Country
- MCD United States
- AZN United Kingdom
- Employees
- MCD N/A
- AZN N/A
- Industry
- MCD Restaurants
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- MCD Consumer Discretionary
- AZN Health Care
- Exchange
- MCD Nasdaq
- AZN Nasdaq
- Market Cap
- MCD 213.7B
- AZN 212.2B
- IPO Year
- MCD N/A
- AZN 1993
- Fundamental
- Price
- MCD $292.71
- AZN $65.35
- Analyst Decision
- MCD Buy
- AZN Buy
- Analyst Count
- MCD 28
- AZN 10
- Target Price
- MCD $320.50
- AZN $88.80
- AVG Volume (30 Days)
- MCD 3.2M
- AZN 5.6M
- Earning Date
- MCD 02-03-2025
- AZN 02-06-2025
- Dividend Yield
- MCD 2.42%
- AZN 2.27%
- EPS Growth
- MCD 0.40
- AZN 9.79
- EPS
- MCD 11.39
- AZN 4.15
- Revenue
- MCD $25,938,700,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- MCD $3.25
- AZN $17.69
- Revenue Next Year
- MCD $3.63
- AZN $7.95
- P/E Ratio
- MCD $25.70
- AZN $30.78
- Revenue Growth
- MCD 3.70
- AZN 13.81
- 52 Week Low
- MCD $243.53
- AZN $60.47
- 52 Week High
- MCD $317.90
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- MCD 44.68
- AZN 41.89
- Support Level
- MCD $288.85
- AZN $66.14
- Resistance Level
- MCD $302.12
- AZN $67.47
- Average True Range (ATR)
- MCD 5.26
- AZN 0.93
- MACD
- MCD -0.54
- AZN -0.03
- Stochastic Oscillator
- MCD 25.82
- AZN 30.45
About MCD McDonald's Corporation
McDonald's is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.